comparemela.com
Home
Live Updates
Dr Dholaria on the Investigation of Noncovalent BTK Inhibito
Dr Dholaria on the Investigation of Noncovalent BTK Inhibito
Dr Dholaria on the Investigation of Noncovalent BTK Inhibitors in CLL
Bhagirathbhai Dholaria, MBBS, discusses the ongoing evaluation of noncovalent BTK inhibitors in patients with chronic lymphocytic leukemia.
Related Keywords
Bhagirathbhai Dholaria ,
Division Of Hematology Oncology ,
Vanderbilt Ingram Cancer Center ,
Bbs ,
Patients With Chronic Lymphocytic Leukemia ,
Noncovalent Btk Inhibitors ,